Myosteatosis Is Associated With Overall Survival in Patients Receiving Pancreatectomy for Pancreatic Neuroendocrine Tumors
ANZ Journal of Surgery · 2025
DOI: 10.1111/ans.70222 ↗Kurz gefasst
Fachartikel in der Zeitschrift ANZ Journal of Surgery, 2025. Verfasst von Dan Jia und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Outpatient, West China Hospital, Sichuan University, Chengdu, China. Hauptthemen laut MEDLINE: Pancreatectomy, Pancreatic Neoplasms, Neuroendocrine Tumors, Muscle, Skeletal. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 35 Literaturangaben.
Abstract (Originalsprache)
Background
To investigate the association of myosteatosis with survival among patients receiving pancreatectomy for pNETs.
Methods
161 patients were enrolled in this retrospective cohort study. Myosteatosis was evaluated using the mean skeletal muscle attenuation with predefined cut‐off values. The impact of potential risk factors on overall survival (OS) and disease‐free survival (DFS) was assessed using the Kaplan–Meier method and the Cox proportional hazards model. A nomogram was constructed based on preoperative survival predictors, and its predictive performance was evaluated using the Receiver Operating Characteristic curve.
Results
Patients with myosteatosis exhibited significantly worse OS ( p = 0.003) than those without myosteatosis. However, there was no statistically significant difference in DFS between patients with myosteatosis and those without myosteatosis ( p = 0.663). In univariate and multivariate analysis, after adjusting for clinicopathological factors, myosteatosis remained an independent predictor of OS (hazard ratio: 4.65; 95% confidence interval: 1.35–15.96; p = 0.02). A nomogram model, incorporating age, myosteatosis, tumor grading, and N status, demonstrated strong performance in estimating OS.
Conclusion
Myosteatosis independently predicts OS in patients undergoing pancreatectomy for pNETs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Outpatient, West China Hospital, Sichuan University, Chengdu, China.
- Division of Pancreatic Surgery, Department of General Surgery, West China Hospital, Sichuan University, Chengdu, China.
- Multi-Disciplinary Treatment Group of Neuroendocrine Tumor. West China Hospital, Sichuan University, Chengdu, China.
- Department of Radiology, West China Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Nengwen Ke
Zitieren
APA
Jia, D., Shen, X., Wang, Z., Yang, F., & Ke, N. (2025). Myosteatosis Is Associated With Overall Survival in Patients Receiving Pancreatectomy for Pancreatic Neuroendocrine Tumors. ANZ Journal of Surgery. https://doi.org/10.1111/ans.70222
Vancouver
Jia D, Shen X, Wang Z, Yang F, Ke N. Myosteatosis Is Associated With Overall Survival in Patients Receiving Pancreatectomy for Pancreatic Neuroendocrine Tumors. ANZ Journal of Surgery. 2025. doi:10.1111/ans.70222
BibTeX
@article{Jia2025,
author = {Jia, Dan and Shen, Xiaoding and Wang, Ziyao and Yang, Fan and Ke, Nengwen},
title = {Myosteatosis Is Associated With Overall Survival in Patients Receiving Pancreatectomy for Pancreatic Neuroendocrine Tumors},
journal = {ANZ Journal of Surgery},
year = {2025},
doi = {10.1111/ans.70222}
}
EUVIMED